Natural Killer Cells Therapeutics Market 2027 by Therapeutics, Application, End User | The Insight Partners

Natural Killer Cells Therapeutics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies); Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others); End User (Research Centers and Institutes , Hospitals, Others)

Report Code: TIPRE00008500 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Natural killer cells lead to immune surveillance against cancer and elimination of small tumor. NK cells are unique, they have the ability to recognize stressed cells in the absence of antibodies and MHC, allowing for a much faster immune reaction.

MARKET DYNAMICS

The natural killer cells therapeutics market is anticipated to rise in the adoption of NK cells for the treatment of cancer, infections, and liver diseases are driving the growth of the natural killer cells therapeutics market. However, higher costs associated with the therapies is restraining market growth. Furthermore, NK cells play a pivotal role in tumor immune-surveillance, which drives market growth.


MARKET SCOPE

The "Natural Killer Cells Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in natural killer cells therapeutics market with detailed market segmentation by therapeutics, application, end user and geography. The natural killer cells therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in natural killer cells therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The natural killer cells therapeutics market is segmented on the basis of therapeutics, application and end user. Based on therapeutics the market is segmented as NK Cell therapies and NK cell directed antibodies. On the basis of application the market is categorized as cancer, gastrointestinal diseases, immunoproliferative disorders and others. On the basis of end user the market is categorized as research centers & institutes, hospitals and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in natural killer cells therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The natural killer cells therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting natural killer cells therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the natural killer cells therapeutics market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in natural killer cells therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in natural killer cells therapeutics market are anticipated to have lucrative growth opportunities in the future with the rising demand for in natural killer cells therapeutics market in the global market. Below mentioned is the list of few companies engaged in the natural killer cells therapeutics market.

The report also includes the profiles of key in natural killer cells therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Affimed GmbH
- Celgene Corporation
- Fate Therapeutics
- Fortress Biotech, Inc.
- Glycostem Therapeutics B.V.
- Innate Pharma S.A.
- Nantkwest Inc.
- Nkarta Therapeutics, Inc.
- NKT Therapeutics Inc.,
- Ziopharm Oncology Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Natural Killer Cells Therapeutics Market - By Therapeutics
1.3.2 Natural Killer Cells Therapeutics Market - By Application
1.3.3 Natural Killer Cells Therapeutics Market - By End User
1.3.4 Natural Killer Cells Therapeutics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NATURAL KILLER CELLS THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NATURAL KILLER CELLS THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. NATURAL KILLER CELLS THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. NATURAL KILLER CELLS THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. NATURAL KILLER CELLS THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NATURAL KILLER CELLS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTICS
7.1. OVERVIEW
7.2. THERAPEUTICS MARKET FORECASTS AND ANALYSIS
7.3. NK CELL THERAPIES
7.3.1. Overview
7.3.2. NK Cell Therapies Market Forecast and Analysis
7.4. NK CELL DIRECTED ANTIBODIES
7.4.1. Overview
7.4.2. NK Cell Directed Antibodies Market Forecast and Analysis
8. NATURAL KILLER CELLS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER
8.3.1. Overview
8.3.2. Cancer Market Forecast and Analysis
8.4. GASTROINTESTINAL DISEASES
8.4.1. Overview
8.4.2. Gastrointestinal Diseases Market Forecast and Analysis
8.5. IMMUNOPROLIFERATIVE DISORDERS
8.5.1. Overview
8.5.2. Immunoproliferative Disorders Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. NATURAL KILLER CELLS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. RESEARCH CENTERS AND INSTITUTES
9.3.1. Overview
9.3.2. Research Centers and Institutes Market Forecast and Analysis
9.4. HOSPITALS
9.4.1. Overview
9.4.2. Hospitals Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. NATURAL KILLER CELLS THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Natural Killer Cells Therapeutics Market Overview
10.1.2 North America Natural Killer Cells Therapeutics Market Forecasts and Analysis
10.1.3 North America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Therapeutics
10.1.4 North America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Application
10.1.5 North America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By End User
10.1.6 North America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Natural Killer Cells Therapeutics Market
10.1.6.1.1 United States Natural Killer Cells Therapeutics Market by Therapeutics
10.1.6.1.2 United States Natural Killer Cells Therapeutics Market by Application
10.1.6.1.3 United States Natural Killer Cells Therapeutics Market by End User
10.1.6.2 Canada Natural Killer Cells Therapeutics Market
10.1.6.2.1 Canada Natural Killer Cells Therapeutics Market by Therapeutics
10.1.6.2.2 Canada Natural Killer Cells Therapeutics Market by Application
10.1.6.2.3 Canada Natural Killer Cells Therapeutics Market by End User
10.1.6.3 Mexico Natural Killer Cells Therapeutics Market
10.1.6.3.1 Mexico Natural Killer Cells Therapeutics Market by Therapeutics
10.1.6.3.2 Mexico Natural Killer Cells Therapeutics Market by Application
10.1.6.3.3 Mexico Natural Killer Cells Therapeutics Market by End User
10.2. EUROPE
10.2.1 Europe Natural Killer Cells Therapeutics Market Overview
10.2.2 Europe Natural Killer Cells Therapeutics Market Forecasts and Analysis
10.2.3 Europe Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Therapeutics
10.2.4 Europe Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Application
10.2.5 Europe Natural Killer Cells Therapeutics Market Forecasts and Analysis - By End User
10.2.6 Europe Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Natural Killer Cells Therapeutics Market
10.2.6.1.1 Germany Natural Killer Cells Therapeutics Market by Therapeutics
10.2.6.1.2 Germany Natural Killer Cells Therapeutics Market by Application
10.2.6.1.3 Germany Natural Killer Cells Therapeutics Market by End User
10.2.6.2 France Natural Killer Cells Therapeutics Market
10.2.6.2.1 France Natural Killer Cells Therapeutics Market by Therapeutics
10.2.6.2.2 France Natural Killer Cells Therapeutics Market by Application
10.2.6.2.3 France Natural Killer Cells Therapeutics Market by End User
10.2.6.3 Italy Natural Killer Cells Therapeutics Market
10.2.6.3.1 Italy Natural Killer Cells Therapeutics Market by Therapeutics
10.2.6.3.2 Italy Natural Killer Cells Therapeutics Market by Application
10.2.6.3.3 Italy Natural Killer Cells Therapeutics Market by End User
10.2.6.4 Spain Natural Killer Cells Therapeutics Market
10.2.6.4.1 Spain Natural Killer Cells Therapeutics Market by Therapeutics
10.2.6.4.2 Spain Natural Killer Cells Therapeutics Market by Application
10.2.6.4.3 Spain Natural Killer Cells Therapeutics Market by End User
10.2.6.5 United Kingdom Natural Killer Cells Therapeutics Market
10.2.6.5.1 United Kingdom Natural Killer Cells Therapeutics Market by Therapeutics
10.2.6.5.2 United Kingdom Natural Killer Cells Therapeutics Market by Application
10.2.6.5.3 United Kingdom Natural Killer Cells Therapeutics Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Natural Killer Cells Therapeutics Market Overview
10.3.2 Asia-Pacific Natural Killer Cells Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Therapeutics
10.3.4 Asia-Pacific Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Natural Killer Cells Therapeutics Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Natural Killer Cells Therapeutics Market
10.3.6.1.1 Australia Natural Killer Cells Therapeutics Market by Therapeutics
10.3.6.1.2 Australia Natural Killer Cells Therapeutics Market by Application
10.3.6.1.3 Australia Natural Killer Cells Therapeutics Market by End User
10.3.6.2 China Natural Killer Cells Therapeutics Market
10.3.6.2.1 China Natural Killer Cells Therapeutics Market by Therapeutics
10.3.6.2.2 China Natural Killer Cells Therapeutics Market by Application
10.3.6.2.3 China Natural Killer Cells Therapeutics Market by End User
10.3.6.3 India Natural Killer Cells Therapeutics Market
10.3.6.3.1 India Natural Killer Cells Therapeutics Market by Therapeutics
10.3.6.3.2 India Natural Killer Cells Therapeutics Market by Application
10.3.6.3.3 India Natural Killer Cells Therapeutics Market by End User
10.3.6.4 Japan Natural Killer Cells Therapeutics Market
10.3.6.4.1 Japan Natural Killer Cells Therapeutics Market by Therapeutics
10.3.6.4.2 Japan Natural Killer Cells Therapeutics Market by Application
10.3.6.4.3 Japan Natural Killer Cells Therapeutics Market by End User
10.3.6.5 South Korea Natural Killer Cells Therapeutics Market
10.3.6.5.1 South Korea Natural Killer Cells Therapeutics Market by Therapeutics
10.3.6.5.2 South Korea Natural Killer Cells Therapeutics Market by Application
10.3.6.5.3 South Korea Natural Killer Cells Therapeutics Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Natural Killer Cells Therapeutics Market Overview
10.4.2 Middle East and Africa Natural Killer Cells Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Therapeutics
10.4.4 Middle East and Africa Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Natural Killer Cells Therapeutics Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Natural Killer Cells Therapeutics Market
10.4.6.1.1 South Africa Natural Killer Cells Therapeutics Market by Therapeutics
10.4.6.1.2 South Africa Natural Killer Cells Therapeutics Market by Application
10.4.6.1.3 South Africa Natural Killer Cells Therapeutics Market by End User
10.4.6.2 Saudi Arabia Natural Killer Cells Therapeutics Market
10.4.6.2.1 Saudi Arabia Natural Killer Cells Therapeutics Market by Therapeutics
10.4.6.2.2 Saudi Arabia Natural Killer Cells Therapeutics Market by Application
10.4.6.2.3 Saudi Arabia Natural Killer Cells Therapeutics Market by End User
10.4.6.3 U.A.E Natural Killer Cells Therapeutics Market
10.4.6.3.1 U.A.E Natural Killer Cells Therapeutics Market by Therapeutics
10.4.6.3.2 U.A.E Natural Killer Cells Therapeutics Market by Application
10.4.6.3.3 U.A.E Natural Killer Cells Therapeutics Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Natural Killer Cells Therapeutics Market Overview
10.5.2 South and Central America Natural Killer Cells Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Therapeutics
10.5.4 South and Central America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Application
10.5.5 South and Central America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By End User
10.5.6 South and Central America Natural Killer Cells Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Natural Killer Cells Therapeutics Market
10.5.6.1.1 Brazil Natural Killer Cells Therapeutics Market by Therapeutics
10.5.6.1.2 Brazil Natural Killer Cells Therapeutics Market by Application
10.5.6.1.3 Brazil Natural Killer Cells Therapeutics Market by End User
10.5.6.2 Argentina Natural Killer Cells Therapeutics Market
10.5.6.2.1 Argentina Natural Killer Cells Therapeutics Market by Therapeutics
10.5.6.2.2 Argentina Natural Killer Cells Therapeutics Market by Application
10.5.6.2.3 Argentina Natural Killer Cells Therapeutics Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NATURAL KILLER CELLS THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. AFFIMED GMBH
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. CELGENE CORPORATION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. FATE THERAPEUTICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. FORTRESS BIOTECH, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLYCOSTEM THERAPEUTICS B.V.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. INNATE PHARMA S.A.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NANTKWEST INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NKARTA THERAPEUTICS, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NKT THERAPEUTICS INC.,
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ZIOPHARM ONCOLOGY INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Affimed GmbH
2. Celgene Corporation
3. Fate Therapeutics
4. Fortress Biotech, Inc.
5. Glycostem Therapeutics B.V.
6. Innate Pharma S.A.
7. Nantkwest Inc.
8. Nkarta Therapeutics, Inc.
9. NKT Therapeutics Inc.,
10. Ziopharm Oncology Inc.
TIPRE00008500
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking